| Impaired glymphatic function and clearance of tau in an Alzheimer’s disease model IF Harrison, O Ismail, A Machhada, N Colgan, Y Ohene, P Nahavandi, ... Brain 143 (8), 2576-2593, 2020 | 305 | 2020 |
| Epigenetic targeting of histone deacetylase: therapeutic potential in Parkinson's disease? IF Harrison, DT Dexter Pharmacology & therapeutics 140 (1), 34-52, 2013 | 246 | 2013 |
| Application of neurite orientation dispersion and density imaging (NODDI) to a tau pathology model of Alzheimer's disease N Colgan, B Siow, JM O'Callaghan, IF Harrison, JA Wells, HE Holmes, ... Neuroimage 125, 739-744, 2016 | 226 | 2016 |
| Non-invasive imaging of CSF-mediated brain clearance pathways via assessment of perivascular fluid movement with diffusion tensor MRI IF Harrison, B Siow, AB Akilo, PG Evans, O Ismail, Y Ohene, P Nahavandi, ... Elife 7, e34028, 2018 | 150 | 2018 |
| Non-invasive MRI of brain clearance pathways using multiple echo time arterial spin labelling: an aquaporin-4 study Y Ohene, IF Harrison, P Nahavandi, O Ismail, EV Bird, OP Ottersen, ... Neuroimage 188, 515-523, 2019 | 122 | 2019 |
| Pathological histone acetylation in Parkinson’s disease: Neuroprotection and inhibition of microglial activation through SIRT 2 inhibition IF Harrison, AD Smith, DT Dexter Neuroscience letters 666, 48-57, 2018 | 110 | 2018 |
| Non-invasive MRI of blood–cerebrospinal fluid barrier function PG Evans, M Sokolska, A Alves, IF Harrison, Y Ohene, P Nahavandi, ... Nature communications 11 (1), 2081, 2020 | 80 | 2020 |
| The Discovery of a Highly Selective 5,6,7,8‐Tetrahydrobenzo[4,5]thieno[2,3‐d]pyrimidin‐4(3H)‐one SIRT2 Inhibitor that is Neuroprotective in an in vitro Parkinson … P Di Fruscia, E Zacharioudakis, C Liu, S Moniot, S Laohasinnarong, ... ChemMedChem 10 (1), 69-82, 2015 | 80 | 2015 |
| Prazosin, an α1-adrenoceptor antagonist, prevents memory deterioration in the APP23 transgenic mouse model of Alzheimer's disease L Katsouri, MP Vizcaychipi, S McArthur, I Harrison, M Suárez-Calvet, ... Neurobiology of aging 34 (4), 1105-1115, 2013 | 77 | 2013 |
| Impaired brain glymphatic flow in experimental hepatic encephalopathy A Hadjihambi, IF Harrison, M Costas-Rodríguez, F Vanhaecke, N Arias, ... Journal of hepatology 70 (1), 40-49, 2019 | 70 | 2019 |
| An animal model mimicking pedunculopontine nucleus cholinergic degeneration in Parkinson’s disease IS Pienaar, IF Harrison, JL Elson, A Bury, P Woll, AK Simon, DT Dexter Brain Structure and Function 220, 479-500, 2015 | 61 | 2015 |
| Tissue magnetic susceptibility mapping as a marker of tau pathology in Alzheimer's disease J O'callaghan, H Holmes, N Powell, JA Wells, O Ismail, IF Harrison, ... Neuroimage 159, 334-345, 2017 | 59 | 2017 |
| Neurorestoration induced by the HDAC inhibitor sodium valproate in the lactacystin model of P arkinson's is associated with histone acetylation and up‐regulation of … IF Harrison, WR Crum, AC Vernon, DT Dexter British journal of pharmacology 172 (16), 4200-4215, 2015 | 56 | 2015 |
| People with Parkinson’s disease: what symptoms do they most want to improve and how does this change with disease duration? RJ Port, M Rumsby, G Brown, IF Harrison, A Amjad, CJ Bale Journal of Parkinson's disease 11 (2), 715-724, 2021 | 48 | 2021 |
| The histone deacetylase inhibitor nicotinamide exacerbates neurodegeneration in the lactacystin rat model of Parkinson's disease IF Harrison, NM Powell, DT Dexter Journal of neurochemistry 148 (1), 136-156, 2019 | 48 | 2019 |
| Comparison of In Vivo and Ex Vivo MRI for the Detection of Structural Abnormalities in a Mouse Model of Tauopathy HE Holmes, NM Powell, D Ma, O Ismail, IF Harrison, JA Wells, N Colgan, ... Frontiers in neuroinformatics 11, 20, 2017 | 47 | 2017 |
| Imaging the accumulation and suppression of tau pathology using multiparametric MRI HE Holmes, N Colgan, O Ismail, D Ma, NM Powell, JM O'Callaghan, ... Neurobiology of aging 39, 184-194, 2016 | 45 | 2016 |
| Propagation of tau and α-synuclein in the brain: therapeutic potential of the glymphatic system DM Lopes, SK Llewellyn, IF Harrison Translational Neurodegeneration 11 (1), 19, 2022 | 28 | 2022 |
| Increased blood–brain barrier permeability to water in the aging brain detected using noninvasive multi‐TE ASL MRI Y Ohene, IF Harrison, PG Evans, DL Thomas, MF Lythgoe, JA Wells Magnetic resonance in medicine 85 (1), 326-333, 2021 | 28 | 2021 |
| L444P Gba1 mutation increases formation and spread of α-synuclein deposits in mice injected with mouse α-synuclein pre-formed fibrils A Migdalska‐Richards, M Wegrzynowicz, IF Harrison, G Verona, V Bellotti, ... PLoS One 15 (8), e0238075, 2020 | 28 | 2020 |
Mark LythgoeProfessor of Biomedical Imaging, University College London在 ucl.ac.uk 的电子邮件经过验证
